SCHEMBL13403657

SCHEMBL13403657

C=C(C)[C@H]1Cc2c(ccc(C3=NOC4(C)COc5cc(OC)c(OC)cc5C34)c2OCC(=O)NCCC)O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.43
▸ MAPT P10636 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ CYP2C19 P33261 3/20 0.43
▸ MT-ND4 P03905 3/20 0.43
▸ CYP2C9 P11712 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GMNN O75496 1/20 0.43
▸ ABCB11 O95342 1/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ MTOR P42345 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ HTR6 P50406 1/20 0.43
▸ RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13267909 0.90 MAPT (0.45) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL13267998 0.81 MAPT (0.49) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL19185149 0.81 MAPT (0.45) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL19828217 0.77 CYP3A4 (0.54) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL13248243 0.77 CYP3A4 (0.52) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL19185196 0.76 CYP3A4 (0.42) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL15744050 0.76 CYP3A4 (0.53) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL13248253 0.75 CYP3A4 (0.51) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL13248250 0.74 CYP3A4 (0.50) CYP3A4MAPTALDH1A1CYP2C19MT-ND4
SCHEMBL13248254 0.74 CYP3A4 (0.48) CYP3A4MAPTALDH1A1CYP2C19MT-ND4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7695929-B2 Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits VENTANA MEDICAL SYSTEMS, INC. (US) 2010-04-13 — — US disclosed
Send feedback